TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biobasiq Sverige AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,379
|
1,622
|
1,573 |
Financial expenses |
4
|
5
|
8 |
Earnings before taxes |
7
|
95
|
172 |
EBITDA |
6
|
100
|
180 |
Total assets |
712
|
661
|
588 |
Current assets |
712
|
661
|
588 |
Current liabilities |
230
|
185
|
152 |
Equity capital |
482
|
476
|
436 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
67.7%
|
72.0%
|
74.1% |
Turnover per employee |
1,190
|
811
|
786 |
Profit as a percentage of turnover |
0.3%
|
5.9%
|
10.9% |
Return on assets (ROA) |
1.5%
|
15.1%
|
30.6% |
Current ratio |
309.6%
|
357.3%
|
386.8% |
Return on equity (ROE) |
1.5%
|
20.0%
|
39.4% |
Change turnover |
752
|
177
|
172 |
Change turnover % |
46%
|
12%
![]() |
12% |
Chg. No. of employees |
0
![]() |
0
|
-1 |
Chg. No. of employees % |
0%
![]() |
0%
|
-33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.